Evaluation of a new assay for measurement of remnant lipoprotein cholesterol in patients with coronary artery disease.

被引：0
|
作者：
Devaraj, S [1 ]
Vega, GL [1 ]
Grundy, SM [1 ]
Jialal, I [1 ]
机构：
[1] UNIV TEXAS,SW MED CTR,DALLAS,TX
来源：
CLINICAL CHEMISTRY | 1997年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：743 / 743
页数：1
相关论文
共 50 条
  • [31] Effect of Ezetimibe/Atorvastatin Combination on Oxidized Low Density Lipoprotein Cholesterol in Patients With Coronary Artery Disease or Coronary Artery Disease Equivalent
    Azar, Rabih R.
    Badaoui, Georges
    Sarkis, Antoine
    Azar, Mireille
    Aydanian, Hermine
    Harb, Serge
    Achkouty, Guy
    Kassab, Roland
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (02): : 193 - 197
  • [32] Remnant Lipoprotein cholesterol levels are elevated in type 2 diabetes and end stage renal disease.
    Hirany, S
    Devaraj, S
    O'Byrne, D
    Jialal, I
    CLINICAL CHEMISTRY, 2000, 46 (06) : A101 - A102
  • [33] New antithrombotic drugs in coronary artery disease.
    Montalescot, G
    REVUE DE MEDECINE INTERNE, 1997, 18 (06): : 450 - 459
  • [34] Chylomicron remnant concentrations in patients with coronary artery disease
    Orth, M
    Dierkes, J
    Luley, C
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (05) : 652 - 662
  • [35] Oxidized low-density lipoprotein cholesterol and the ratio in the diagnosis and evaluation of therapeutic effect in patients with coronary artery disease
    Huang, Huiling
    Ma, R.
    Liu, Dan
    Liu, Chen
    Ma, Yuedong
    Mai, Weiyi
    Dong, Yugang
    DISEASE MARKERS, 2012, 33 (06) : 295 - 302
  • [36] Development of a Novel Homogeneous Assay for Remnant Lipoprotein Particle Cholesterol
    Hirao, Yuhko
    Nakajima, Katsuyuki
    Machida, Tetsuo
    Murakami, Masami
    Ito, Yasuki
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2018, 3 (01): : 26 - 36
  • [37] Limitations of Automated Remnant Lipoprotein Cholesterol Assay for Diagnostic Use
    Schaefer, Ernst J.
    CLINICAL CHEMISTRY, 2009, 55 (11) : 2061 - 2062
  • [38] Lipoprotein (HDL)-associated oxidized phospholipids and their role in coronary artery disease.
    Dayal, B
    Ertel, NH
    Shmidt, E
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U324 - U324
  • [39] Comparison of remnant-like lipoprotein particles in postmenopausal women with and without coronary artery disease and in men with coronary artery disease
    Fukushima, H
    Kugiyama, K
    Sugiyama, S
    Honda, O
    Koide, S
    Nakamura, S
    Kawano, H
    Soejima, H
    Miyamoto, S
    Yoshimura, M
    Sakamoto, T
    Ogawa, H
    AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (12): : 1370 - 1373
  • [40] ASSOCIATION OF LIPOPROTEIN(A) WITH CORONARY ARTERY DISEASE IN PERIPHERAL ARTERY DISEASE PATIENTS
    Tmoyan, N. A.
    Ezhov, M. V.
    Afanasieva, O. I.
    Klesareva, E. A.
    Afanasieva, M. I.
    Chubykina, U. V.
    Pokrovsky, S. N.
    ATHEROSCLEROSIS, 2022, 355 : E72 - E72
12345